Roche Holding AG

Roche Holding AGverified

RHHVF

Price:

$287.04

Market Cap:

$206.79B

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discov...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2009-02-13

Stock Exchange

PNK

Ticker

RHHVF

The Enterprise Value as of November 2024 (TTM) for Roche Holding AG (RHHVF) is 238.14B

According to Roche Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 238.14B. This represents a change of 7.21% compared to the average of 222.12B of the last 4 quarters.

Roche Holding AG (RHHVF) Historical Enterprise Value (quarterly & annually)

How has RHHVF Enterprise Value performed in the past?

The mean historical Enterprise Value of Roche Holding AG over the last ten years is 251.72B. The current 238.14B Enterprise Value has changed 9.36% with respect to the historical average. Over the past ten years (40 quarters), RHHVF's Enterprise Value was at its highest in in the December 2021 quarter at 338.60B. The Enterprise Value was at its lowest in in the June 2018 quarter at 204.54B.

Quarterly (TTM)
Annual

Average

251.72B

Median

251.21B

Minimum

215.82B

Maximum

340.47B

Roche Holding AG (RHHVF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Roche Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 27.82%

Maximum Annual Enterprise Value = 340.47B

Minimum Annual Increase = -26.03%

Minimum Annual Enterprise Value = 215.82B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023217.94B-13.46%
2022251.84B-26.03%
2021340.47B27.82%
2020266.36B-3.92%
2019277.24B25.71%
2018220.54B-1.46%
2017223.81B3.70%
2016215.82B-14.56%
2015252.61B0.81%
2014250.58B10.24%

Roche Holding AG (RHHVF) Average Enterprise Value

How has RHHVF Enterprise Value performed in the past?

The current Enterprise Value of Roche Holding AG (RHHVF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

270.08B

5-year avg

270.77B

10-year avg

251.72B

Roche Holding AG (RHHVF) Enterprise Value vs. Peers

How is RHHVF’s Enterprise Value compared to its peers?

Roche Holding AG’s Enterprise Value is greater than AstraZeneca PLC (234.40B), greater than Roche Holding AG (227.52B), greater than Roche Holding AG (234.35B), greater than Grifols, S.A. (6.05B), greater than Novartis AG (222.02B), greater than Scilex Holding Company (199.99M), greater than Novartis AG (222.57B), greater than Bristol-Myers Squibb Company PFD CONV 2 (183.67B), less than Astellas Pharma Inc. (0), less than Sanofi (3.37T), greater than AstraZeneca PLC (133.10B), greater than GSK plc (230.26B), greater than Bayer Aktiengesellschaft (52.06B), greater than Bristol-Myers Squibb Company (14.80B), greater than null (162.91B),

CompanyEnterprise ValueMarket cap
234.40B$207.63B
227.52B$219.64B
234.35B$227.29B
6.05B$6.98B
222.02B$203.47B
199.99M$112.45M
222.57B$204.02B
183.67B$140.16B
0$17.33B
3.37T$121.05B
133.10B$203.49B
230.26B$69.26B
52.06B$20.24B
14.80B$119.40B
162.91B$0

Build a custom stock screener for Roche Holding AG (RHHVF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Roche Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Roche Holding AG (RHHVF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Roche Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Roche Holding AG's Enterprise Value?

What is the highest Enterprise Value for Roche Holding AG (RHHVF)?

What is the 3-year average Enterprise Value for Roche Holding AG (RHHVF)?

What is the 5-year average Enterprise Value for Roche Holding AG (RHHVF)?

How does the current Enterprise Value for Roche Holding AG (RHHVF) compare to its historical average?